![Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris](https://escholarship.org/content/qt0n81z2h4/2.jpg)
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris
![These highlights do not include all the information needed to use TAZAROTENE CREAM safely and effectively. See full prescribing information for TAZAROTENE CREAM. TAZAROTENE cream, for topical use Initial U.S. Approval: 1997 These highlights do not include all the information needed to use TAZAROTENE CREAM safely and effectively. See full prescribing information for TAZAROTENE CREAM. TAZAROTENE cream, for topical use Initial U.S. Approval: 1997](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=60g-tube.jpg&id=642832)
These highlights do not include all the information needed to use TAZAROTENE CREAM safely and effectively. See full prescribing information for TAZAROTENE CREAM. TAZAROTENE cream, for topical use Initial U.S. Approval: 1997
![These highlights do not include all the information needed to use TAZORAC® Cream safely and effectively. See full prescribing information for TAZORAC® Cream. TAZORAC® (tazarotene) cream, 0.05% and 0.1%, for topical use These highlights do not include all the information needed to use TAZORAC® Cream safely and effectively. See full prescribing information for TAZORAC® Cream. TAZORAC® (tazarotene) cream, 0.05% and 0.1%, for topical use](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=tazorac-03.jpg&id=677382)